Novartis will acquire the German manufacturer of cancer medications.

Published Date: 07 Feb 2024

With the agreement to purchase German biotech company MorphoSys for 2 point7 billion euros ($2 point9 billion), the multinational pharmaceutical company Novartis, based in Switzerland, announced this week that it would acquire a new treatment for blood cancer.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The Boom in ADHD Coaching Has Few Rules

2.

Cancer patients with HIV have demonstrated safety with immune checkpoint inhibitors.

3.

The FDA approves Enhertu for HER2-positive cancers, regardless of tumor type.

4.

Medicaid expansion tied to smaller declines in early-stage cancer detection

5.

Specialist Referrals Are Critical for Functional High-Risk Multiple Myeloma


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot